A detailed history of Baird Financial Group, Inc. transactions in Thermo Fisher Scientific Inc. stock. As of the latest transaction made, Baird Financial Group, Inc. holds 214,742 shares of TMO stock, worth $113 Million. This represents 0.26% of its overall portfolio holdings.

Number of Shares
214,742
Previous 219,754 2.28%
Holding current value
$113 Million
Previous $122 Million 9.3%
% of portfolio
0.26%
Previous 0.26%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$531.86 - $624.21 $2.67 Million - $3.13 Million
-5,012 Reduced 2.28%
214,742 $133 Million
Q2 2024

Aug 13, 2024

BUY
$541.52 - $599.02 $7.19 Million - $7.96 Million
13,285 Added 6.43%
219,754 $122 Million
Q1 2024

May 14, 2024

BUY
$528.82 - $599.43 $949,760 - $1.08 Million
1,796 Added 0.88%
206,469 $120 Million
Q4 2023

Feb 14, 2024

BUY
$431.41 - $532.94 $31.9 Million - $39.4 Million
73,984 Added 56.61%
204,673 $109 Million
Q3 2023

Nov 13, 2023

SELL
$498.29 - $574.41 $355,779 - $410,128
-714 Reduced 0.54%
130,689 $66.2 Million
Q2 2023

Aug 11, 2023

SELL
$508.46 - $591.13 $34.5 Million - $40.1 Million
-67,895 Reduced 34.07%
131,403 $68.6 Million
Q1 2023

May 15, 2023

BUY
$535.0 - $604.82 $966,745 - $1.09 Million
1,807 Added 0.91%
199,298 $115 Million
Q3 2022

Nov 14, 2022

BUY
$507.19 - $604.49 $8.05 Million - $9.59 Million
15,868 Added 8.61%
200,214 $102 Million
Q2 2022

Aug 08, 2022

BUY
$500.9 - $612.21 $1.51 Million - $1.85 Million
3,015 Added 1.66%
184,346 $100 Million
Q1 2022

May 13, 2022

BUY
$524.0 - $644.92 $336,932 - $414,683
643 Added 0.36%
181,331 $107 Million
Q4 2021

Feb 09, 2022

BUY
$569.0 - $667.24 $2.71 Million - $3.18 Million
4,766 Added 2.71%
180,688 $121 Million
Q3 2021

Nov 12, 2021

SELL
$509.53 - $609.78 $418,324 - $500,629
-821 Reduced 0.46%
175,922 $101 Million
Q2 2021

Aug 11, 2021

BUY
$441.0 - $508.24 $220,941 - $254,628
501 Added 0.28%
176,743 $89.2 Million
Q1 2021

May 13, 2021

BUY
$439.85 - $518.83 $4.01 Million - $4.73 Million
9,109 Added 5.45%
176,242 $80.4 Million
Q4 2020

Feb 11, 2021

BUY
$435.06 - $527.66 $3.5 Million - $4.24 Million
8,041 Added 5.05%
167,133 $77.8 Million
Q3 2020

Nov 12, 2020

BUY
$359.77 - $441.52 $2.26 Million - $2.78 Million
6,290 Added 4.12%
159,092 $70.2 Million
Q2 2020

Oct 22, 2020

BUY
$275.2 - $362.34 $8.25 Million - $10.9 Million
29,994 Added 24.42%
152,802 $55.4 Million
Q2 2020

Aug 14, 2020

SELL
$275.2 - $362.34 $885,868 - $1.17 Million
-3,219 Reduced 2.55%
122,808 $39.9 Million
Q1 2020

May 14, 2020

SELL
$255.3 - $340.05 $1.86 Million - $2.47 Million
-7,266 Reduced 5.45%
126,027 $35.7 Million
Q4 2019

Feb 14, 2020

BUY
$271.93 - $328.04 $2.57 Million - $3.1 Million
9,453 Added 7.63%
133,293 $43.3 Million
Q3 2019

Nov 14, 2019

BUY
$268.46 - $305.43 $10.9 Million - $12.4 Million
40,711 Added 48.97%
123,840 $36.1 Million
Q2 2019

Aug 14, 2019

BUY
$257.51 - $295.55 $2.02 Million - $2.32 Million
7,837 Added 10.41%
83,129 $24.4 Million
Q1 2019

May 14, 2019

SELL
$212.17 - $273.72 $87,414 - $112,772
-412 Reduced 0.54%
75,292 $20.6 Million
Q4 2018

Feb 14, 2019

BUY
$208.47 - $251.98 $1.77 Million - $2.14 Million
8,501 Added 12.65%
75,704 $16.9 Million
Q3 2018

Nov 13, 2018

BUY
$205.57 - $244.32 $432,108 - $513,560
2,102 Added 3.23%
67,203 $16.7 Million
Q2 2018

Aug 13, 2018

BUY
$203.14 - $219.53 $463,565 - $500,967
2,282 Added 3.63%
65,101 $13.5 Million
Q1 2018

May 14, 2018

SELL
$192.98 - $224.11 $57,315 - $66,560
-297 Reduced 0.47%
62,819 $13 Million
Q4 2017

Feb 09, 2018

BUY
$182.03 - $200.37 $120,139 - $132,244
660 Added 1.06%
63,116 $12 Million
Q3 2017

Nov 14, 2017

SELL
$171.74 - $194.04 $499,763 - $564,656
-2,910 Reduced 4.45%
62,456 $11.8 Million
Q2 2017

Aug 14, 2017

BUY
N/A
65,366
65,366 $11.4 Million

Others Institutions Holding TMO

About THERMO FISHER SCIENTIFIC INC.


  • Ticker TMO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 391,788,992
  • Market Cap $205B
  • Description
  • Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as di...
More about TMO
Track This Portfolio

Track Baird Financial Group, Inc. Portfolio

Follow Baird Financial Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Baird Financial Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Baird Financial Group, Inc. with notifications on news.